MedAxiom Announces Industry Partnership with Itamar Medical
Itamar Medical, providing complete sleep solutions to cardiac patients.
Partner News | Published: Wednesday, August 19, 2020
MedAxiom, the nation’s leading cardiovascular healthcare membership organization and performance community, is excited to announce its industry partnership with Itamar Medical®, a publicly-traded medical device company focused on improving cardiovascular outcomes by leading the integration of Sleep Apnea management into the cardiac patient care pathway.
“Itamar Medical facilitates an all-in-one program for Cardiologists’ patients to be diagnosed and treated for sleep apnea with no cost to the prescribing physicians and clinics.” said Joe Sasson Ph.D., EVP of MedAxiom Ventures. “We are excited to welcome them as a MedAxiom Industry Partner and bring their important solutions to our membership community.”
Itamar Medical, together with its ecosystem partners, created WatchPAT®; TurnKey, a completely remote, home-based and seamless care pathway for sleep apnea management. The program provides a scalable model for managing large patient volumes while reducing wait times for diagnosis and treatment and overall cost. Patients are able to complete the sleep study within the comfort of their own home to show more accurate sleep habits. The data is then reviewed by a board certified in sleep physician before providing an interpreted report to the cardiologist.
“There are 92 million cardiovascular patients in the US with more than 50% of them estimated to suffer from sleep apnea. Although it is well established that effective sleep apnea management in those patients can improve overall cardiovascular health and treatment outcomes, and lead to reduced mortality rates, still 80% of those patients remain undiagnosed and untreated. When a cardiologist refers patients to sleep apnea diagnosis and treatment, today’s traditional care pathway is long, cumbersome, and expensive.” said Gilad Glick, President and CEO of Itamar Medical. “Our WatchPAT Turn Key program minimizes the burden to both cardiology clinics and patients, and reduces it to a simple ordered prescription while enabling full transparency of the care pathway, high level of patient service and satisfaction rates and professional clinical solutions based on a digital health platform that yields higher then average completion and compliance rates.”
Itamar Medical is aiming at improving cardiovascular outcomes by simplifying patient access to sleep apnea care. The WatchPAT TurnKey program reduces time to treatment from months to 2 weeks on average. Patients are then monitored and supported, and cardiologists are provided data through a digital compliance dashboard. The integration of Sleep Apnea management into the cardiac patient care pathway is improving long term treatment adherence (from 33% to 67% on average) and almost 100% patient satisfaction.
MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s largest membership and resources network and the leading cardiovascular-specific consulting team in the U.S. MedAxiom is transforming cardiovascular care by combining the knowledge and power of more than 400 cardiovascular organization members and thousands of providers, administrators and clinicians. Through the delivery of proprietary tools, smart data and proven strategies, MedAxiom helps cardiovascular organizations achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience.
For additional information, visit www.MedAxiom.com.
About Itamar Medical
Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. Itamar Medical commercializes a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets. Itamar Medical offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare system costs. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA.
For additional information, visit: www.itamar-medical.com.